WILMINGTON, Del., July 6, 2007 (PRIME NEWSWIRE) -- Rx Processing Corporation (Pink Sheets:RXPC), a source of low-cost prescription medications and diagnostic laboratory tests for millions of Americans, announces the board of directors cancels the July stock dividend announced June 19th 2007.
Rx Processing Corp., with the board of directors, today moved to cancel the July stock dividend as to continue the evaluation on the severity of our operational issues in furtherance of the overall mission.
Chairman Peter Fiorillo stated, "I have been left with no choice but to cancel this stock dividend to further my (our) mission to service the under and uninsured due to financial and technology issues along with the complete erosion of our share price."
Rx Processing Corp., an innovator in the distribution of pharmaceutical medications and laboratory diagnostics managed through storefront locations, is deploying a direct to consumer delivery business model that fulfills the needs of under and uninsured clients' health care needs. The company provides access to FDA approved brand-name and generic medications, thousands of laboratory diagnostics with access to 4,000+ CLIA-certified patient service centers for specimen collection. Rx Processing Corp. estimates that more than 48 million United States citizens would benefit from these company programs.
Safe Harbor Statement:
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including those about the company's future expectations, revenues and earnings, and all other forward-looking statements (i.e. operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated.